Hikma Pharmaceuticals (LON:HIK – Get Free Report) had its price objective hoisted by Barclays from GBX 1,700 ($21.87) to GBX 1,800 ($23.16) in a research report issued on Wednesday, Marketbeat.com reports. The firm presently has an “equal weight” rating on the stock. Barclays‘s target price indicates a potential downside of 1.13% from the company’s current […]
Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,765.20 ($22.71) and traded as high as GBX 1,859.99 ($23.93). Hikma Pharmaceuticals shares last traded at GBX 1,818.50 ($23.40), with a volume of 232,671 shares changing hands. […]
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 […]
Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Free Report) traded up 8.1% on Tuesday . The company traded as high as $49.65 and last traded at $49.65. 445 shares were traded during trading, a decline of 67% from the average session volume of 1,340 shares. The stock had previously closed at $45.94. Hikma Pharmaceuticals Stock […]
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Rating) shares reached a new 52-week high during trading on Thursday . The company traded as high as $24.00 and last traded at $24.00, with a volume of 0 shares traded. The stock had previously closed at $24.00. Analysts Set New Price Targets HKMPF has been the subject of […]